- Pulmonary vein isolation with very high power, short duration, temperature-controlled lesions: the QDOT-FAST trial.JACC Clin Electrophysiol. 2019; 5: 778-786
- High-power and short-duration ablation for pulmonary vein isolation: safety, efficacy, and long-term durability.J Cardiovasc Electrophysiol. 2018; 29: 1287-1296
- High-power and short-duration ablation for pulmonary vein isolation: biophysical characterization.JACC Clin Electrophysiol. 2018; 4: 467-479
- High-power short-duration versus standard radiofrequency ablation: Insights on lesion metrics.J Cardiovasc Electrophysiol. 2018; 29: 1570-1575
- Safety and outcome of very high-power short-duration ablation using 70 W for pulmonary vein isolation in patients with paroxysmal atrial fibrillation.Europace. 2020; 22: 388-393
- Saline-irrigated radiofrequency ablation electrode with external cooling.J Cardiovasc Electrophysiol. 2005; 16: 323-328
- Temperature-controlled radiofrequency ablation for pulmonary vein isolation in patients with atrial fibrillation.J Am Coll Cardiol. 2017; 70: 542-553
- Temperature-controlled radiofrequency ablation using irrigated catheters: maximizing ventricular lesion dimensions while reducing steam-pop formation.JACC Clin Electrophysiol. 2020; 6: 83-93
- Histopathologic characterization of chronic radiofrequency ablation lesions for pulmonary vein isolation.J Am Coll Cardiol. 2012; 59: 930-938
Funding sources: This study received financial support from the French Government as part of the “Investments of the Future” program managed by the National Research Agency (The French National Research Agency Grant ID: ANR-10-IAHU-04).
Disclosures: Drs Haïssaguerre, Hocini, Jaïs, and Sacher have received lecture fees from Biosense Webster and Abbott. Drs Martin, Denis, Derval, Jaïs, and Sacher have received speaking honoraria and consulting fees from Boston Scientific. Miss Kristine Fuimaono, Mr Keshava Datta, and Miss Helee Joshi are employees of Biosense Webster. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
∗Drs Masateru Takigawa and Takeshi Kitamura contributed equally to this work.